Albemarle financials
$107.62+0.21%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.74B | $1.43B | $1.43B | $1.31B | $1.33B | $1.08B | $1.23B | $1.35B | $1.43B | $1.36B | $2.36B | $2.31B |
| Gross profit | $590.3M | $501.0M | $197.9M | $117.6M | $196.9M | $156.3M | $138.2M | -$104.0M | -$10.6M | $38.9M | -$704.1M | $54.9M |
| Gross margin | 33.9% | 35.1% | 13.9% | 9.0% | 14.8% | 14.5% | 11.2% | −7.7% | −0.7% | 2.9% | −29.9% | 2.4% |
| Operating income | $452.9M | $328.5M | -$217.4M | -$217.0M | $47.5M | $19.8M | $4.4M | -$1.11B | -$492.6M | -$179.5M | -$921.1M | -$140.0M |
| Net income | $438.3M | $277.4M | -$455.9M | -$202.4M | -$18.8M | -$340.0K | $33.6M | -$1.11B | -$229.9M | -$9.1M | -$617.7M | $302.5M |
| Net margin | 25.1% | 19.4% | −31.9% | −15.5% | −1.4% | 0.0% | 2.7% | −82.0% | −16.1% | −0.7% | −26.2% | 13.1% |
| Diluted EPS | $3.52 | $2.34 | $-3.87 | $-1.72 | $-0.16 | $0.00 | $0.29 | $-9.45 | $-1.96 | $-0.08 | $-5.25 | $2.57 |
| EBITDA | $616.1M | $512.2M | $194.0M | $130.8M | $220.7M | $180.5M | $145.3M | -$117.2M | -$59.5M | -$22.2M | -$920.8M | -$32.8M |
| Operating cash flow | $710.0M | $346.2M | $388.5M | $355.6M | -$9.0M | $547.2M | -$4.4M | $227.1M | $367.2M | $98.0M | -$98.2M | $628.9M |
| Free cash flow | $638.3M | $247.6M | $233.1M | $223.4M | -$128.7M | $364.6M | -$347.2M | -$76.0M | -$88.1M | -$481.4M | -$782.3M | $83.0M |
| Diluted shares | 136.2M | 118.6M | 117.7M | 117.7M | 117.7M | 117.6M | 117.6M | 117.5M | 117.5M | 117.5M | 117.7M | 117.8M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $1.63B | $1.09B | $1.62B | $1.93B | $1.81B | $1.52B |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $1.88B | $1.88B | $3.19B | $3.63B | $3.62B | $3.54B |
| Total assets | $15.91B | $15.14B | $16.37B | $17.15B | $17.29B | $17.00B |
| Total liabilities | $5.37B | $5.03B | $6.59B | $6.88B | $6.79B | $6.72B |
| Shareholders' equity | $10.53B | $10.11B | $9.78B | $10.27B | $10.50B | $10.27B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology